Your browser doesn't support javascript.
loading
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients.
Nyssen, Olga P; Bordin, Dmitry; Tepes, Bojan; Pérez-Aisa, Ángeles; Vaira, Dino; Caldas, Maria; Bujanda, Luis; Castro-Fernandez, Manuel; Lerang, Frode; Leja, Marcis; Rodrigo, Luís; Rokkas, Theodore; Kupcinskas, Limas; Pérez-Lasala, Jorge; Jonaitis, Laimas; Shvets, Oleg; Gasbarrini, Antonio; Simsek, Halis; Axon, Anthony T R; Buzás, György; Machado, Jose Carlos; Niv, Yaron; Boyanova, Lyudmila; Goldis, Adrian; Lamy, Vincent; Tonkic, Ante; Przytulski, Krzysztof; Beglinger, Christoph; Venerito, Marino; Bytzer, Peter; Capelle, Lisette; Milosavljevic, Tomica; Milivojevic, Vladimir; Veijola, Lea; Molina-Infante, Javier; Vologzhanina, Liudmila; Fadeenko, Galina; Ariño, Ines; Fiorini, Giulia; Garre, Ana; Garrido, Jesús; F Pérez, Cristina; Puig, Ignasi; Heluwaert, Frederic; Megraud, Francis; O'Morain, Colm; Gisbert, Javier P.
Afiliación
  • Nyssen OP; Gastroenterolgy Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain.
  • Bordin D; Department of Pancreatic, Biliary and Upper Digestive Tract Disorders, AS Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation.
  • Tepes B; A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation.
  • Pérez-Aisa Á; Gastroenterology, AM DC Rogaska, Rogaska Slatina, Slovenia.
  • Vaira D; Gastroenterology, Agencia Sanitaria Costa del Sol, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Marbella, Spain.
  • Caldas M; Department of of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
  • Bujanda L; Gastroenterolgy Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain.
  • Castro-Fernandez M; Gastroenterology, Hospital Donostia/Instituto Biodonostia, Universidad del País Vasco (UPV/EHU), CIBEREHD, San Sebastian, Spain.
  • Lerang F; Gastroenterology, Hospital de Valme, CIBEREHD, Sevilla, Spain.
  • Leja M; Gastroenterololgy, Østfold Hospital Trust, Grålum, Norway.
  • Rodrigo L; Digestive Diseases Centre GASTRO, Institute of Clinical and Preventive Medicine & Faculty of Medicine, University of Latvia, Riga, Latvia.
  • Rokkas T; Gastroenterology, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Kupcinskas L; Gastroenterology, Henry Dunant Hospital, Athens, Greece.
  • Pérez-Lasala J; Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Jonaitis L; Gastroenterology, HM Sanchinarro, Madrid, Spain.
  • Shvets O; Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Gasbarrini A; Internal Medicine, National Medical University named after O.O.Bogomolets, Kyiv, Ukraine.
  • Simsek H; Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy.
  • Axon ATR; Internal Medicine/Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Buzás G; Gastroenterology, Leeds General Infirmary, Leeds, UK.
  • Machado JC; Gastroenterology, Ferencváros Health Centre, Budapest, Hungary.
  • Niv Y; i3S - Instituto de Investigação e Inovação em Saúde. Medical Faculty of Porto. Universidade do Porto, Porto, Portugal.
  • Boyanova L; Gastroenterology, Rabin Medical Center, Tel Aviv University, Petah Tikva, Israel.
  • Goldis A; Medical Microbiology, Medical University of Sofia, Sofia, Bulgaria.
  • Lamy V; Gastroenterology, Timisoara Hospital, Timisoara, Romania.
  • Tonkic A; Gastroenterology, Hepatology & Nutrition, CHU de Charleroi, Charleroi, Belgium.
  • Przytulski K; Gastroenterology, University Hospital of Split, University of Split, Split, Croatia.
  • Beglinger C; Gastroenterology, Medical Centre for Postgraduate Education, Warsaw, Poland.
  • Venerito M; Gastroenterology, University Hospital Basel, Basel, Switzerland.
  • Bytzer P; Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany.
  • Capelle L; Clinical Medicine, Zealand University Hospital, Copenhagen University, Copenhagen, Denmark.
  • Milosavljevic T; Gastroenterology and Hepatology, Meander Medical Center, Amersfoort, Netherlands.
  • Milivojevic V; Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia and School of Medicine, University of Belgrade, Belgrade, Serbia.
  • Veijola L; Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia and School of Medicine, University of Belgrade, Belgrade, Serbia.
  • Molina-Infante J; Internal Medicine, Herttoniemi Hospital, Helsinki, Finland.
  • Vologzhanina L; Gastroenterology, Hospital San Pedro de Alcántara, CIBEREHD, Cáceres, Spain.
  • Fadeenko G; Gastroenterology, Gastrocentr, Perm, Russian Federation.
  • Ariño I; Gastroenterology, Digestive Ukrainian Academy of Medical Sciences, Kyiv, Ukraine.
  • Fiorini G; Gastroenterology, Hospital Clinico Universitario Lozano Blesa, CIBEREHD, Zaragoza, Spain.
  • Garre A; Department of of Surgical and Medical Sciences, University of Bologna, Bologna, Italy.
  • Garrido J; Gastroenterolgy Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain.
  • F Pérez C; Departmento de Psicología Social y Metodología, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid, Spain.
  • Puig I; Servicio de Medicina Preventiva, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
  • Heluwaert F; Gastroenterology, Althaia Xarxa Assistencial Universitària de Manresa and Universitat de Vic-Universitat Central de Catalunya (UVicUCC), Manresa, Spain.
  • Megraud F; Centre Hospitalier Annecy Genevois, Pringy, France.
  • O'Morain C; Laboratoire de Bactétiologie, Hôpital Pellegrin, Bordeaux, France.
  • Gisbert JP; Gastroenterology, Trinity College Dublin, Dublin, Ireland.
Gut ; 70(1): 40-54, 2021 01.
Article en En | MEDLINE | ID: mdl-32958544
ABSTRACT

OBJECTIVE:

The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care.

DESIGN:

International multicentre prospective non-interventional registry starting in 2013 aimed to evaluate the decisions and outcomes in H. pylori management by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap. Variables included demographics, previous eradication attempts, prescribed treatment, adverse events and outcomes. Data monitoring was performed to ensure data quality. Time-trend and geographical analyses were performed.

RESULTS:

30 394 patients from 27 European countries were evaluated and 21 533 (78%) first-line empirical H. pylori treatments were included for analysis. Pretreatment resistance rates were 23% to clarithromycin, 32% to metronidazole and 13% to both. Triple therapy with amoxicillin and clarithromycin was most commonly prescribed (39%), achieving 81.5% modified intention-to-treat eradication rate. Over 90% eradication was obtained only with 10-day bismuth quadruple or 14-day concomitant treatments. Longer treatment duration, higher acid inhibition and compliance were associated with higher eradication rates. Time-trend analysis showed a region-dependent shift in prescriptions including abandoning triple therapies, using higher acid-inhibition and longer treatments, which was associated with an overall effectiveness increase (84%-90%).

CONCLUSION:

Management of H. pylori infection by European gastroenterologists is heterogeneous, suboptimal and discrepant with current recommendations. Only quadruple therapies lasting at least 10 days are able to achieve over 90% eradication rates. European recommendations are being slowly and heterogeneously incorporated into routine clinical practice, which was associated with a corresponding increase in effectiveness.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Helicobacter pylori / Infecciones por Helicobacter / Inhibidores de la Bomba de Protones / Antibacterianos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Gut Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Helicobacter pylori / Infecciones por Helicobacter / Inhibidores de la Bomba de Protones / Antibacterianos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Gut Año: 2021 Tipo del documento: Article País de afiliación: España